SHP2 has been implicated in breast carcinogenesis [21], and SHP2 mutations are found in several types of solid tumors as well as in two syndromes, Leopard and Noonan syndrome, where it makes patients prone to multiple types of cancer [19, 22, 23]. This evidence concerns the gene PTPN11 and Noonan syndrome.